These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38891907)

  • 1. Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.
    Alotaibi AZ; AlMalki RH; Al Mogren M; Sebaa R; Alanazi M; Jacob M; Alodaib A; Alfares A; Abdel Rahman AM
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
    Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening of maple syrup urine disease and the effect of early diagnosis.
    Chen T; Lu D; Xu F; Ji W; Zhan X; Gao X; Qiu W; Zhang H; Liang L; Gu X; Han L
    Clin Chim Acta; 2023 Aug; 548():117483. PubMed ID: 37421976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved ultra performance liquid chromatography-tandem mass spectrometry method for the determination of alloisoleucine and branched chain amino acids in dried blood samples.
    Alodaib A; Carpenter K; Wiley V; Sim K; Christodoulou J; Wilcken B
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):468-70. PubMed ID: 21775576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P; Brown L; Massey S; Ramamoorthy S
    Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots.
    Sebaa R; AlMogren M; Alseraty W; Abdel Rahman AM
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.
    Couce ML; Ramos F; Bueno MA; Díaz J; Meavilla S; Bóveda MD; Fernández-Marmiesse A; García-Cazorla A
    Eur J Paediatr Neurol; 2015 Nov; 19(6):652-9. PubMed ID: 26232051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
    Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population.
    Lin N; Ye J; Qiu W; Han L; Zhang H; Gu X
    J Pediatr Endocrinol Metab; 2013; 26(5-6):433-9. PubMed ID: 23412862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatographic diagnosis of maple syrup urine disease by measuring the L-alloisoleucine/L-phenylalanine ratio in dried blood spots.
    Jeong JS; Sim HJ; Lee YM; Yoon HR; Kwon HJ; Hong SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2171-4. PubMed ID: 21680261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry.
    Chace DH; Hillman SL; Millington DS; Kahler SG; Roe CR; Naylor EW
    Clin Chem; 1995 Jan; 41(1):62-8. PubMed ID: 7813082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline.
    Fingerhut R
    Eur J Pediatr; 2009 May; 168(5):599-604. PubMed ID: 18682982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland.
    O'Reilly D; Crushell E; Hughes J; Ryan S; Rogers Y; Borovickova I; Mayne P; Riordan M; Awan A; Carson K; Hunter K; Lynch B; Shahwan A; Rüfenacht V; Häberle J; Treacy EP; Monavari AA; Knerr I
    J Inherit Metab Dis; 2021 May; 44(3):639-655. PubMed ID: 33300147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
    Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
    Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.
    Coene KLM; Kluijtmans LAJ; van der Heeft E; Engelke UFH; de Boer S; Hoegen B; Kwast HJT; van de Vorst M; Huigen MCDG; Keularts IMLW; Schreuder MF; van Karnebeek CDM; Wortmann SB; de Vries MC; Janssen MCH; Gilissen C; Engel J; Wevers RA
    J Inherit Metab Dis; 2018 May; 41(3):337-353. PubMed ID: 29453510
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.